StockTipsArenaBeta

BUY GlaxoSmithKline Pharmaceuticals Limited — Rakesh Bansal

BUYGlaxoSmithKline Pharmaceuticals Limited
GlaxoSmithKline Pharmaceuticals share price target & all analyst calls

byRakesh BansalHorizon: 1–3 months19 Aug 2026via Zee Business (Live)

Entry₹2,982.5Inferred
Target₹3,700
Total upside +24.06%
Stop lossNot given
CMP₹2,433.71h ago
Active-18.40%+52.03%upside left 4 wk left
Follow Rakesh Bansal for new calls(31% target hit, 26 closed calls)Get alertsWatch GLAXO for new buy/sell callsGet alertsSee 43 other Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 22 Oct, 5:35 pm IST
10 supporting4 neutral1 opposing
Supports the BUY call (10)

RSI at 17 — oversold territory

Technicals · rsi·22 Oct · today

Neutral / worth noting (4)

Q2 FY27 results scheduled — board meets 03 Nov 2026

BSE · Board Meeting·In 11 days

(opens in new tab)
Weighs against the BUY call (1)

MACD below its signal line — bearish momentum

Technicals · macd·22 Oct · today

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on GlaxoSmithKline Pharmaceuticals

All analyst calls on GlaxoSmithKline Pharmaceuticals

More from Rakesh Bansal

Every call and its outcome